AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Learn more →

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

GlaxoSmithKline

🇬🇧United Kingdom

Country: 🇬🇧United Kingdom

Ownership: Public

Established: 1929-01-01

Employees: 70.2K

Market Cap: $90B

Website: http://www.gsk.com

Introduction: GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the Commercial Operations, and Research and Development segments. The Commercial Operations segment has three product groups of specialty medicines, vaccines, and general medicines. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.

Clinical Trials

A Study Investigating the Pharmacokinetic Profiles of Four Extended Release Paracetamol Formulations

Phase 1

Completed

Conditions: Analgesia

Interventions: Drug: Paracetamol formulation 4
Drug: Paracetamol formulation 1
Drug: Paracetamol formulation 3
Drug: Paracetamol Formulation 2
Drug: Paracetamol

First Posted Date: 2012-04-02

Last Posted Date: 2014-11-24

Lead Sponsor: GlaxoSmithKline

Target Recruit Count: 14

Registration Number: NCT01568749

Locations: 🇺🇸
MDS Pharma Services ARIZONA, Phoenix, Arizona, United States

Post-marketing Surveillance to Assess the Safety of Infanrix-IPV Vaccine Among Infants and Children in Korea

Completed

Conditions: Acellular Pertussis
Diphtheria
Diphtheria-Tetanus-acellular Pertussis Vaccines
Tetanus
Poliomyelitis

Interventions: Other: Infanrix-IPV data collection

First Posted Date: 2012-04-02

Last Posted Date: 2023-01-27

Lead Sponsor: GlaxoSmithKline

Target Recruit Count: 645

Registration Number: NCT01568060

Locations: 🇰🇷
GSK Investigational Site, Seoul, Korea, Republic of

Randomised, Double-blind, Placebo-controlled Study of Topical Clobetasone Butyrate 0.05% Cream in Subjects With Eczema for Two Weeks to Evaluate the Efficacy and Safety

Phase 3

Completed

Conditions: Eczema

Interventions: Drug: Clobetasone Butyrate 0.05% Cream
Drug: Vehicle (base cream)

First Posted Date: 2012-04-02

Last Posted Date: 2017-11-28

Lead Sponsor: GlaxoSmithKline

Target Recruit Count: 240

Registration Number: NCT01567995

Locations: 🇨🇳
GSK Investigational Site, Tianjin, China

Effect of Dentifrice Usage Regime on Delivery and Efficacy of Fluoride

Phase 4

Completed

Conditions: Dental Caries

Interventions: Drug: Sodium fluoride / silica and carbopol, 0.5g
Drug: Sodium fluoride / silica and carbopol, 1.5g
Other: Fluoride free dentifrice

First Posted Date: 2012-03-26

Last Posted Date: 2018-02-07

Lead Sponsor: GlaxoSmithKline

Target Recruit Count: 65

Registration Number: NCT01563172

Locations: 🇺🇸
Indiana University School of Dentistry, Indianapolis, Indiana, United States

Exploratory Efficacy Study of Guaifenesin in Upper Back Pain

Not Applicable

Completed

Conditions: Upper Back Pain

Interventions: Drug: Placebo
Drug: Guaifenesin

First Posted Date: 2012-03-26

Last Posted Date: 2014-06-03

Lead Sponsor: GlaxoSmithKline

Target Recruit Count: 78

Registration Number: NCT01562548

Locations: 🇺🇸
Radiant Research, Inc. - TX, San Antonio, Texas, United States
🇺🇸
Med Investigations, Fair Oaks, California, United States
🇺🇸
J. Lewis Research, Salt Lake City, Utah, United States

and more 2 locations